Showing 571-580 of 2046 results for "".
Telemedicine Is Increasing Patient Access to Eye Care
https://modernod.com/topics/technology/telemedicine-is-increasing-patient-access-to-eye-care/38038/A look at the technology’s applications and limitations.How Digital Health Helps Differentiate Your Optometric Practice
https://modernod.com/topics/business/how-digital-health-helps-differentiate-your-optometric-practice/38733/Understand what digital health is and learn how it can distinguish your clinic now and in the future.The Challenges of Benzalkonium Chloride in Glaucoma Care
https://modernod.com/topics/glaucoma/the-challenges-of-benzalkonium-chloride-in-glaucoma-care/54304/A look at the cytotoxic effects on the ocular surface, and the potential of preservative-free medications.Alcon Gains FDA Approval for Novel DED Drug
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-gains-fda-approval-for-novel-ded-drug/37087/Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more abUtilizing AI to Provide DR Screening to Underserved Communities
https://modernod.com/podcasts/eyewire-news-the-podcast/utilizing-ai-to-provide-dr-screening-to-underserved-communities/37079/EyewireTV speaks with the leaders of Digital Diagnostics and AEYE Health about their diabetic screening technology, racial and socioeconomic disparities in eye care, and their mission to improve health equity by expanding their technology into underserved populations. Learn more about your ad choiceFDA Approves First Treatment for MacTel
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-first-treatment-for-mactel/37075/The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision testing platform. Learn more about your ad choices. VisAlcon Acquires Staar for $1.5 Billion
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-staar-for-15-billion/37096/Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week. Learn more about your ad choices.What to Do With Noncompliant Dry Eye Patients
https://modernod.com/podcasts/to-the-point/what-to-do-with-noncompliant-dry-eye-patients/36895/Do you have patients who find it difficult to stick with their dry eye treatment plans? In this episode of To the Point, Leslie and Jackie discuss how they have handled various noncompliant patient situations. The hosts also provide tips for increasing patient adherence to treatment plans and improvStruggling With Reimbursements for In-Office MGD Procedures?
https://modernod.com/topics/ocular-surface/struggling-with-reimbursements-for-in-office-mgd-procedures/38465/Try these tips for some of the most commonly used therapies.An Adjustable Option for Cataract Surgery
https://modernod.com/mod-issues/2019-sept/an-adjustable-option-for-cataract-surgery/39080/What the Light Adjustable Lens means for patients and eye care providers.